PubRank

Peter Charbel Issa

Author PubWeight™ 45.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 2011 2.64
2 A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss. Hum Genet 2006 2.27
3 Systemic complement activation in age-related macular degeneration. PLoS One 2008 2.18
4 High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 2008 2.03
5 An update on the genetics of age-related macular degeneration. Mol Vis 2007 1.95
6 Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches. Surv Ophthalmol 2009 1.92
7 Reversal of end-stage retinal degeneration and restoration of visual function by photoreceptor transplantation. Proc Natl Acad Sci U S A 2013 1.58
8 Genetic control of the alternative pathway of complement in humans and age-related macular degeneration. Hum Mol Genet 2010 1.57
9 Clinical evaluation of simultaneous confocal scanning laser ophthalmoscopy imaging combined with high-resolution, spectral-domain optical coherence tomography. Acta Ophthalmol 2010 1.44
10 Increasing the yield in targeted next-generation sequencing by implicating CNV analysis, non-coding exons and the overall variant load: the example of retinal dystrophies. PLoS One 2013 1.40
11 Truncating mutation of the DFNB59 gene causes cochlear hearing impairment and central vestibular dysfunction. Hum Mutat 2007 1.38
12 The role of the complement system in age-related macular degeneration. Dtsch Arztebl Int 2014 1.34
13 Treatment of choroidal neovascularization due to angioid streaks: a comprehensive review. Retina 2013 1.24
14 Reading performance is reduced by parafoveal scotomas in patients with macular telangiectasia type 2. Invest Ophthalmol Vis Sci 2008 1.23
15 Long-term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum. Retina 2011 1.22
16 Monthly ranibizumab for choroidal neovascularizations secondary to angioid streaks in pseudoxanthoma elasticum: a one-year prospective study. Am J Ophthalmol 2011 1.22
17 Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia. Retina 2008 1.15
18 Familial asymptomatic macular telangiectasia type 2. Ophthalmology 2009 1.12
19 Tracking progression with spectral-domain optical coherence tomography in geographic atrophy caused by age-related macular degeneration. Invest Ophthalmol Vis Sci 2010 1.06
20 In vivo imaging of foveal sparing in geographic atrophy secondary to age-related macular degeneration. Invest Ophthalmol Vis Sci 2009 1.00
21 Complement regulation at necrotic cell lesions is impaired by the age-related macular degeneration-associated factor-H His402 risk variant. J Immunol 2011 0.95
22 An update on the ocular phenotype in patients with pseudoxanthoma elasticum. Front Genet 2013 0.94
23 First symptoms and their age of onset in macular telangiectasia type 2. Retina 2014 0.91
24 Outer retinal hyperreflective spots on spectral-domain optical coherence tomography in macular telangiectasia type 2. Ophthalmology 2010 0.90
25 Spectral domain optical coherence tomography in adult-onset vitelliform macular dystrophy with cuticular drusen. Retina 2010 0.90
26 A new diagnostic approach in patients with type 2 macular telangiectasia: confocal reflectance imaging. Acta Ophthalmol 2007 0.88
27 Correlation of lines of increased autofluorescence in macular dystrophy and pigmented paravenous retinochoroidal atrophy by optical coherence tomography. Arch Ophthalmol 2008 0.86
28 Routes for Drug Delivery to the Eye and Retina: Intravitreal Injections. Dev Ophthalmol 2015 0.85
29 Neurologic and ocular phenotype in Pitt-Hopkins syndrome and a zebrafish model. Hum Genet 2011 0.84
30 Characterization of a dominant cone degeneration in a green fluorescent protein-reporter mouse with disruption of Loci associated with human dominant retinal dystrophy. Invest Ophthalmol Vis Sci 2011 0.84
31 The relative impact of vision impairment and cardiovascular disease on quality of life: the example of pseudoxanthoma elasticum. Health Qual Life Outcomes 2011 0.83
32 High-resolution optical coherence tomography of subpigment epithelial structures in patients with pigment epithelium detachment secondary to age-related macular degeneration. Br J Ophthalmol 2012 0.82
33 Vesicular stomatitis virus glycoprotein- and Venezuelan equine encephalitis virus-derived glycoprotein-pseudotyped lentivirus vectors differentially transduce corneal endothelium, trabecular meshwork, and human photoreceptors. Hum Gene Ther 2013 0.82
34 Fundus autofluorescence in Pseudoxanthoma elasticum. Retina 2009 0.81
35 The Retina Hotline: eighteen-month results from a telephone hotline for patients with retinal diseases. Retina 2010 0.80
36 Treatment for Macular Telangiectasia Type 2. Dev Ophthalmol 2015 0.79
37 Specific deficits in visual electrophysiology in a mouse model of dominant optic atrophy. Exp Eye Res 2011 0.79
38 A novel control mechanism based on GDNF modulation of somatostatin release from sensory neurones. FASEB J 2002 0.78
39 Analysis of glutathione S-transferase Pi isoform (GSTP1) single-nucleotide polymorphisms and macular telangiectasia type 2. Int Ophthalmol 2010 0.75
40 The article by Kovach and Rosenfeld. Retina 2009 0.75
41 Author Response: Reticular Pseudodrusen: A Common Pathogenic Mechanism Affecting the Choroid-Bruch's Membrane Complex and Retinal Pigment Epithelium for Different Retinal and Macular Diseases. Invest Ophthalmol Vis Sci 2015 0.75
42 No evidence to support the use of plasmapheresis for age-related macular degeneration. Ther Apher Dial 2010 0.75
43 X-linked juvenile retinoschisis in a consanguineous family: phenotypic variability and report of a homozygous female patient. Retina 2014 0.75
44 Morphologic outer retinal abnormalities in white dot syndromes on spectral-domain optical coherence tomography. Clin Experiment Ophthalmol 2012 0.75
45 CHOROIDAL ALTERATIONS IN ABCA4-RELATED RETINOPATHY. Retina 2017 0.75
46 Cone photoreceptor neuroprotection conferred by CNTF in a novel in vivo model of battlefield retinal laser injury. Invest Ophthalmol Vis Sci 2013 0.75
47 POOR LONG-TERM OUTCOME OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN NONPROLIFERATIVE MACULAR TELANGIECTASIA TYPE 2. Retina 2015 0.75
48 Plasmapheresis for dry age-related macular degeneration--evidence based? Retina 2009 0.75